title: Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice.
abstract: Live attenuated vaccines against measles have been developed through adaptation of clinical isolates of measles virus (MV) in various cultured cells. Analyses using recombinant MVs with chimeric genomes between wild-type and Edmonston vaccine strains indicated that viruses possessing the polymerase protein genes of the Edmonston strain exhibited attenuated viral gene expression and growth in cultured cells as well as in mice expressing an MV receptor, signaling lymphocyte activation molecule, regardless of whether the virus genome had the wild-type or vaccine-type promoter sequence. These data demonstrate that the polymerase protein genes of the Edmonston strain contribute to its attenuated phenotype.
authors.affiliation: Department of Virology, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. mtakeda@virology.med.kyushu-u.ac.jp
authors.forename: Makoto
authors.initials: M
authors.lastname: Takeda
authors.forename: Shinji
authors.initials: S
authors.lastname: Ohno
authors.forename: Maino
authors.initials: M
authors.lastname: Tahara
authors.forename: Hiroki
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Yuta
authors.initials: Y
authors.lastname: Shirogane
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Ohmura
authors.forename: Takafumi
authors.initials: T
authors.lastname: Nakamura
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Yanagi
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000502:physiology*; D002522:Chlorocebus aethiops; D049452:Green Fluorescent Proteins / Q000235:genetics; D008458:Measles Vaccine / Q000276:immunology*; D008459:Measles virus / Q000235:genetics*; D051379:Mice; D012367:RNA, Viral / Q000096:biosynthesis; D012324:RNA-Dependent RNA Polymerase / Q000235:genetics* / Q000276:immunology; D011956:Receptors, Cell Surface / Q000235:genetics / Q000502:physiology*; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D014613:Vaccines, Attenuated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D014709:Vero Cells
chemical_list: D015703:Antigens, CD; D008458:Measles Vaccine; D012367:RNA, Viral; D011956:Receptors, Cell Surface; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D012324:RNA-Dependent RNA Polymerase
references.citation: Virology. 2006 Apr 25;348(1):107-19
references.pmid: 16445957
references.citation: J Virol. 2005 Dec;79(24):15218-25
references.pmid: 16306593
references.citation: J Virol. 2007 Mar;81(6):2564-72
references.pmid: 17182683
references.citation: Gene. 1991 Dec 15;108(2):193-9
references.pmid: 1660837
references.citation: Virology. 2008 Mar 30;373(1):39-50
references.pmid: 18155263
references.citation: J Virol. 1998 Nov;72(11):8690-6
references.pmid: 9765410
references.citation: Virology. 2008 Apr 25;374(1):71-81
references.pmid: 18234267
references.citation: J Virol. 1999 Aug;73(8):6903-15
references.pmid: 10400788
references.citation: J Virol. 2005 Nov;79(22):14346-54
references.pmid: 16254369
references.citation: J Virol. 1994 Mar;68(3):1532-43
references.pmid: 8107216
references.citation: Virus Res. 2006 Dec;122(1-2):78-84
references.pmid: 16889863
references.citation: J Virol. 2002 Jul;76(13):6743-9
references.pmid: 12050387
references.citation: Virology. 2007 Mar 30;360(1):72-83
references.pmid: 17112561
references.citation: Virus Res. 1994 Mar;31(3):317-30
references.pmid: 8191786
references.citation: Nature. 2000 Aug 24;406(6798):893-7
references.pmid: 10972291
references.citation: J Virol. 2007 Jul;81(13):6827-36
references.pmid: 17442724
references.citation: EMBO J. 1995 Dec 1;14(23):5773-84
references.pmid: 8846771
references.citation: Virology. 2006 Apr 25;348(1):96-106
references.pmid: 16442140
references.citation: J Virol. 2001 May;75(9):4399-401
references.pmid: 11287589
references.citation: Virology. 2007 Nov 25;368(2):351-62
references.pmid: 17686504
references.citation: J Gen Virol. 2002 Jun;83(Pt 6):1431-1436
references.pmid: 12029158
references.citation: J Virol. 2000 May;74(9):4139-45
references.pmid: 10756026
references.citation: Virology. 2005 May 25;336(1):120-9
references.pmid: 15866077
references.citation: Virology. 1980 Aug;105(1):205-22
references.pmid: 7414950
references.citation: J Virol. 2007 Feb;81(4):1650-9
references.pmid: 17135325
references.citation: J Virol. 2008 Sep;82(17):8296-306
references.pmid: 18562542
references.citation: EMBO J. 1987 Mar;6(3):681-8
references.pmid: 3582370
references.citation: J Virol. 2000 Jul;74(14):6643-7
references.pmid: 10864679
references.citation: J Virol. 2002 Jul;76(14):7073-81
references.pmid: 12072507
references.citation: Proc Soc Exp Biol Med. 1954 Jun;86(2):277-86
references.pmid: 13177653
references.citation: Virology. 1999 Apr 10;256(2):340-50
references.pmid: 10191199
references.citation: J Virol. 2005 Jun;79(11):6900-8
references.pmid: 15890929
references.citation: J Virol. 2007 Nov;81(21):12091-6
references.pmid: 17715217
references.citation: J Gen Virol. 2006 Oct;87(Pt 10):2767-2779
references.pmid: 16963735
references.citation: J Virol. 1990 Feb;64(2):700-5
references.pmid: 2153236
references.citation: Virus Genes. 2008 Feb;36(1):35-44
references.pmid: 18040767
references.citation: Virology. 1987 Oct;160(2):523-6
references.pmid: 3660593
references.citation: Eur J Immunol. 1995 Apr;25(4):976-84
references.pmid: 7737301
references.citation: J Gen Virol. 2004 Oct;85(Pt 10):2991-2999
references.pmid: 15448362
references.citation: Nat Rev Microbiol. 2006 Dec;4(12):900-8
references.pmid: 17088933
references.citation: Virology. 2001 Jun 20;285(1):100-9
references.pmid: 11414810
references.citation: J Virol Methods. 2006 Oct;137(1):152-5
references.pmid: 16854475